Hims & Hers Health, Inc. HIMS is scheduled to report second-quarter 2025 results on Aug. 4, after the closing bell. In the ...

Hims & Hers Health ranks highest in Revenue Growth among its peers. It also leads in Gross Profit margin. However, it has the ...

One of the most widely watched names in the healthcare sector is Hims & Hers Health Inc. (NYSE: HIMS), not only due to its ...

According to Benzinga Pro, Hims & Hers Health's peer group average for short interest as a percentage of float is 8.31%, which means the company has more short interest than most of its peers. Did you ...

Healthcare Triangle, Inc. (Nasdaq: HCTI) ("HCTI" or the "Company"), a leader in digital transformation solutions including managed services, cloud enablement, and data analytics for the healthcare and ...

The Trump administration is considering a five-year pilot program to cover weight-loss drugs under Medicare and Medicaid, the ...

WHAT’S NEXT? If you suffered a loss in Hims & Hers Health, Inc. during the relevant time frame, you have until August 25, 2025 to request that the Court appoint you as lead plaintiff. Your ability to ...

BBC fans are just discovering an "incredible" period drama adapted from one of the most famous novels of all time ...

Sawatch Labs Acquisition & Strong Liquidity Aids WEX (WEX) Per the Zacks analyst, Sawatch Labs' buyout assists WEX in ...

Lyft (LYFT) closed the most recent trading day at $13.62, moving -3.13% from the previous trading session. This move lagged the S&P 500's daily loss of 1.6%. At the same time, the Dow lost 1.23% ...

In the latest trading session, Jabil (JBL) closed at $218.56, marking a -2.07% move from the previous day. The stock trailed the S&P 500, which registered a daily loss of 1.6%. Meanwhile, the Dow ...

Eli Lilly is set to report Q2 2025 earnings on August 7, with consensus expecting $14.4 billion in revenue and $5.56 EPS, up 30-42% YoY. Learn more on LLY stock here.